Literature DB >> 27569727

Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin.

Vadim V Klimontov1, Natalia E Myakina2.   

Abstract

AIM: O determine the applicability of glucose variability (GV) indices derived from continuous glucose monitoring (CGM) data for prediction of nocturnal hypoglycemia (NH) in elderly patients with type 2 diabetes treated with insulin.
METHODS: We observed 83 insulin-treated in-patients, 65-80 years of age. Blinded CGM data for 176 nights were analyzed. Daytime (06:00-22:59) mean glucose, Standard Deviation (SD), 2-h Continuous Overlapping Net Glycemic Action (CONGA2) and Mean Absolute Glucose (MAG), pre-midnight (23:00-23:59) mean glucose, SD and MAG, 24-h Mean Amplitude of Glucose Excursions (MAGE), were estimated. Pre-midnight glucose trends were estimated as the absolute difference between glucose values at 23:00 and 23:59 (deltaG). Episode of interstitial glucose ≤70mg/dL observed from 0:00 to 5:59 was considered as NH.
RESULTS: NH was present in 68 out of 176 24-h recordings (39%). Lower daytime mean glucose and CONGA2, and higher MAG values were found in patients with NH as compared to those without (p=0.0002, p=0.0001 and p=0.02, respectively). Pre-midnight mean glucose was lower, while pre-midnight deltaG was higher in patients with NH (p<0.0001 and p=0.02). Antecedent daytime hypoglycemia increased the risk of NH (p<0.0001). In logistic regression analysis, the combination of daytime MAG and pre-midnight mean glucose was the most reliable predictor of subsequent NH (accuracy 75.6%, p=0.0004).
CONCLUSION: The analysis of CGM-derived GV parameters could improve prediction of NH in elderly patients with type 2 diabetes treated with insulin.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Continuous glucose monitoring; Glucose variability; Hypoglycemia; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27569727     DOI: 10.1016/j.dsx.2016.08.023

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  20 in total

Review 1.  Closing the Loop.

Authors:  Revital Nimri; Nathan Murray; Alexander Ochs; Jordan E Pinsker; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2017-02       Impact factor: 6.118

Review 2.  Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.

Authors:  Guillermo E Umpierrez; Boris P Kovatchev
Journal:  Am J Med Sci       Date:  2018-10-02       Impact factor: 2.378

3.  Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Alexandra K Lee; Clare J Lee; Elbert S Huang; A Richey Sharrett; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2017-09-19       Impact factor: 19.112

Review 4.  How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?

Authors:  Ramzi A Ajjan
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 5.  Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.

Authors:  Anders L Carlson; Deborah M Mullen; Richard M Bergenstal
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

6.  Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.

Authors:  Shoubi Wang; Zhenhua Tan; Ting Wu; Qingbao Shen; Peiying Huang; Liying Wang; Wei Liu; Haiqu Song; Mingzhu Lin; Xiulin Shi; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

7.  Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus.

Authors:  Takahiro Ishikawa; Masaya Koshizaka; Yoshiro Maezawa; Minoru Takemoto; Yoshiharu Tokuyama; Toshihiro Saito; Koutaro Yokote
Journal:  J Diabetes Investig       Date:  2017-05-24       Impact factor: 4.232

Review 8.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

9.  Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring.

Authors:  Maiko Hajime; Yosuke Okada; Hiroko Mori; Fumi Uemura; Satomi Sonoda; Kenichi Tanaka; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Yoshiya Tanaka
Journal:  Diabetol Metab Syndr       Date:  2019-02-15       Impact factor: 3.320

10.  Insomnia and Mild Cognitive Impairment.

Authors:  R C Hamdy; A Kinser; K Dickerson; T Kendall-Wilson; A Depelteau; R Copeland; K Whalen
Journal:  Gerontol Geriatr Med       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.